Novartis pays $310 million upfront for inflammation specialist IFM

United States News News

Novartis pays $310 million upfront for inflammation specialist IFM
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Novartis on Monday said it had agreed to pay $310 million (£238 million) upfront...

FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

ZURICH - Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker seeks to expand its immunology pipeline. The deal for the IFM subsidiary IFM Tre could eventually reach nearly $1.6 billion, IFM said in a statement, should the portfolio of clinical and preclinical molecules meet milestones. IFM has one molecule, IFM-2427, in an early Phase 1 trial, as well as other less-developed assets.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Duke to pay $112.5 million to settle allegation of falsifying research for federal grantsDuke to pay $112.5 million to settle allegation of falsifying research for federal grantsDuke University will pay the US government $112.5 million to settle allegations of falsifying research in order to obtain millions of dollars in federal grants, the Department of Justice announced
Read more »

U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialU.S. jury says Bayer must pay $81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. The jury in San Francisco federal court said the company was liable for
Read more »

Millions Are Being Lost To Apple Pay Fraud—Will Apple Card Come To The Rescue?Millions Are Being Lost To Apple Pay Fraud—Will Apple Card Come To The Rescue?Fraud perpetrated via Apple Pay might be the biggest yet, with other digital wallets abused too. Apple Card could prevent fraudsters loading up wallets with stolen credit card data.
Read more »

U.S. jury says Bayer must pay $80 million to man in Roundup cancer trialU.S. jury says Bayer must pay $80 million to man in Roundup cancer trialJury awards $80 million to man who claimed Bayer's Roundup weed killer caused his non-Hodgkin's lymphoma
Read more »

The 5 highest-paid CEOs of 2018, including $129 million for Discovery's David ZaslavThe 5 highest-paid CEOs of 2018, including $129 million for Discovery's David ZaslavThe highest-paid CEOs of 2018 include Discovery's David Zaslav and Disney's Bob Iger.
Read more »

GE Capital Pays $49 Million Over Petters Ponzi SchemeGE Capital Pays $49 Million Over Petters Ponzi SchemeGeneral Electric Capital Corp. reached the deal with a bankruptcy trustee who is digging up money for investors in two Florida hedge funds that lost $650 million when the Ponzi scheme collapsed in 2008, according to court papers entered Tuesday in the U.S. District Court in West Palm Beach, Fla.
Read more »

OxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseOxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseThe case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.
Read more »



Render Time: 2025-02-26 09:37:24